Strong Revenue Growth
Revenue increased by 10.8% year-over-year to $185.9 million, marking the best three revenue quarters in CRA's history.
International Expansion
International operations expanded by 30.3% year-over-year, driven by Antitrust & Competition Economics and Life Sciences practices.
Antitrust & Competition Economics Success
The Antitrust & Competition Economics practice achieved a new high for quarterly revenue, contributing to major M&A activities, including advising UnitedHealth Group and Microsoft.
Increased Profitability
Non-GAAP net income, earnings per diluted share, and EBITDA increased by 12.7%, 16.4%, and 14.6% respectively.
Dividend Increase
Announced a 16% increase in quarterly cash dividend from $0.49 to $0.57 per common share.
Robust Energy Practice
Energy practice led revenue increase by 8% year-over-year, advising on major utility projects and market design initiatives.